Inventor · disambiguated record
Akane Ishihara
Also filed as: ISHIHARA AKANE
13 granted patents·3 pending applications·445 citations·filing 2000–2006
93Inventor score
Top patents by PatentIndex Score
16 records- 0197US6335345B1Spiro compoundsBANYU PHARMA CO LTD·Filed 2001·Granted Jan 1, 2002·120 cites·27 claims
- 0297US6326375B1Spiro compoundsBANYU PHARMA CO LTD·Filed 2000·Granted Dec 4, 2001·148 cites·19 claims
- 0394US7064142B2Imidazonline compoundsBANYU PHARMA CO LTD·Filed 2001·Granted Jun 20, 2006·54 cites·9 claims
- 0492US6649624B2Spiro compoundsBANYU PHARMA CO LTD·Filed 2002·Granted Nov 18, 2003·27 cites·10 claims
- 0590US6462053B1Spiro compoundsBANYU PHARMA CO LTD·Filed 2002·Granted Oct 8, 2002·21 cites·6 claims
- 0689US6723847B2Spiro compoundsBANYU PHARMA CO LTD·Filed 2003·Granted Apr 20, 2004·17 cites·7 claims
- 0789US6388077B1Spiro compoundsBANYU PHARMA CO LTD·Filed 2001·Granted May 14, 2002·28 cites·3 claims
- 0886US6803372B2Spiro compoundsBANYU PHARMA CO LTD·Filed 2002·Granted Oct 12, 2004·23 cites·41 claims
- 0966US7541477B2Antagonists to melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredientBANYU PHARMA CO LTD·Filed 2003·Granted Jun 2, 2009·3 cites·22 claims
- 1064US7485647B22-aminoquinoline derivativesBANYU PHARMA CO LTD·Filed 2004·Granted Feb 3, 2009·2 cites·11 claims
- 1164US7304072B2Spiro compoundsBANYU PHARMA CO LTD·Filed 2004·Granted Dec 4, 2007·2 cites·14 claims
- 1258US7482358B2Imidazoline compoundsBANYU PHARMA CO LTD·Filed 2006·Granted Jan 27, 2009·0 cites·15 claims
- 1350US2005288213A1Combination therapy for the treatment of obesityMACNEIL DOUGLAS J·Filed 2003·Application pending·0 cites
- 1444US7510833B2Method for examining obesity or leannessBANYU PHARMA CO LTD·Filed 2004·Granted Mar 31, 2009·0 cites·1 claims
- 1544US2010184648A1Therapeutic agent for non-alcoholic fatty liver disease, and screening method for drug candidate compound for treatment or prevention of non-alcoholic fatty liver diseaseGOMORI AKIRA·Filed 2006·Application pending·0 cites
- 1641US2010137391A1Histamine H3 Agonist for use as Therapeutic Agent for a Lipid/Glucose Metabolic DisorderYOSHIMOTO RYO·Filed 2006·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →